Development and external validation of a LASSO-based parsimonious nomogram for predicting BPPV recurrence: a multi-center retrospective cohort study - Scorecard - MDSpire

Development and external validation of a LASSO-based parsimonious nomogram for predicting BPPV recurrence: a multi-center retrospective cohort study

  • By

  • Qiaozhi Jin

  • Ziyuan Chen

  • Yong Li

  • Yilong Wang

  • Changyu Duan

  • Yongjie Ying

  • Fude Jin

  • June 15, 2026

  • 0 min

Share

Clinical Scorecard: Creation and external validation of a simplified nomogram utilizing LASSO for forecasting recurrence of BPPV: a multi-center retrospective cohort analysis

At a Glance

CategoryDetail
ConditionBenign Paroxysmal Positional Vertigo (BPPV)
Key MechanismsDislodgment of otoconia leading to canalithiasis or cupulolithiasis.
Target PopulationPatients diagnosed with BPPV.
Care SettingOtolaryngology departments in multi-center hospitals.

Key Highlights

  • 1-year recurrence rate of BPPV was 23.97%.
  • Core variables for recurrence risk: Diabetes Mellitus, Non-posterior canal involvement, 25-hydroxyvitamin D deficiency.
  • Model demonstrated good discrimination with AUC values of 0.905 (training), 0.872 (internal validation), and 0.853 (external validation).
  • Calibration curves showed excellent agreement between predicted and observed probabilities.
  • Nomogram facilitates early identification of high-risk patients.

Guideline-Based Recommendations

Diagnosis

  • Confirmed diagnosis of BPPV based on clinical criteria.

Management

  • Canalith Repositioning Procedures (CRP) such as Epley and Barbecue maneuvers.

Monitoring & Follow-up

  • Regular follow-up to assess recurrence risk and manage symptoms.

Risks

  • High incidence of recurrence leading to falls and psychological distress.

Patient & Prescribing Data

Patients diagnosed with BPPV from two medical centers.

Focus on personalized recurrence risk stratification using identified core variables.

Clinical Best Practices

  • Utilize the developed nomogram for risk stratification in clinical practice.
  • Consider metabolic, anatomical, and nutritional markers in patient assessments.
  • Implement targeted secondary prevention strategies for high-risk patients.

Related Resources & Content

Original Source(s)

Related Content